Bank of Nova Scotia’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
DGM
VPM
VCM
BBA
Bank of Nova Scotia's INSM Position: Q1 2026 in Review
Bank of Nova Scotia reduced its Insmed (INSM) stake by 75% in Q1 2026, selling an estimated $7.01M and leaving 15,203 shares worth $2.49M. The position accounts for ﹤0.01% of the portfolio, ranked #707.
Bank of Nova Scotia first reported a position in INSM in Q3 2025 and has held it in 3 quarters since. The position peaked at $72.9M in Q3 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Bank of Nova Scotia held 15,203 shares of Insmed worth $2.49M as of Q1 2026.
- Bank of Nova Scotia sold 45,572 Insmed shares in Q1 2026, an estimated $7.01M.
- Insmed made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #707 holding.
- Bank of Nova Scotia first reported a position in Insmed in Q3 2025 and has held it in 3 quarters since.
- Bank of Nova Scotia's Insmed position peaked at $72.9M in Q3 2025.
- 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.